Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
Portfolio Pulse from
Addex Therapeutics reported a significant net loss in its provisional third quarter 2024 results compared to the second quarter. However, the company remains on track for a net profit for the nine-month period.
November 11, 2024 | 6:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Addex Therapeutics reported a significant net loss in Q3 2024 compared to Q2, but is still on track for a net profit for the nine-month period.
The significant net loss in Q3 compared to Q2 suggests potential short-term negative sentiment around Addex's financial performance. However, the company's guidance of a net profit for the nine-month period may mitigate some concerns. Investors may react negatively in the short term due to the immediate loss, but the overall trajectory remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100